The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...
Oct 2, 2023
0
8
A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.
Sep 29, 2023
0
3
A formulation for intravenous nutrition that includes four lipid sources, including fish oil, reduced hospitalizations and urinary tract infections among pediatric patients at Duke Children's Hospital.
Sep 6, 2023
0
3
The Food and Drug Administration has approved a vaccine for pregnant women to provide immediate protection against respiratory syncytial virus, or RSV, in infants.
Aug 22, 2023
0
3
The U.S. Food & Drug Administration has approved Akeega (niraparib and abiraterone acetate) for the treatment of BRCA-positive metastatic castration-resistant prostate cancer.
Aug 18, 2023
0
2
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in ...
Jun 16, 2023
0
9
Medicare will soon cover a new class of Alzheimer's drugs if they receive full approval from the U.S. Food and Drug Administration, with some key limits.
Jun 2, 2023
0
14
Since its founding in 2016, Elon Musk's neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain implant with at least 100 times more brain connections than devices currently approved ...
May 30, 2023
0
9
The Food and Drug Administration (FDA) in the U.S. has authorized the first approved drug for a rare form of motor neuron disease (MND) based on the results of a Phase 3 clinical trial completed at the University of Sheffield, ...
May 1, 2023
0
7
